Antimicrobial prophylaxis for surgery: An advisory statement from the national surgical infection prevention project

Clinical Infectious Diseases

Volumn 38, Issue 12, 2004, Pages 1706-1715

  Bratzler, Dale W ^a   Houck, Peter M ^b  

^a OK Found for Medical Quality   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZTREONAM; BETA LACTAM; CEFAZOLIN; CEFOTETAN; CEFOXITIN; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; NEOMYCIN; PENICILLIN G; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ABDOMINAL HYSTERECTOMY; ANTIMICROBIAL THERAPY; BACTERIUM CONTAMINATION; CESAREAN SECTION; CLINICAL TRIAL; CLOSTRIDIUM DIFFICILE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG FEVER; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; GYNECOLOGIC SURGERY; HIP ARTHROPLASTY; HUMAN; INFECTION PREVENTION; KNEE ARTHROPLASTY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; OBSTETRIC OPERATION; ORTHOPEDIC SURGERY; PENICILLIN ALLERGY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SURGICAL INFECTION; TOXIC EPIDERMAL NECROLYSIS; VAGINAL HYSTERECTOMY;

ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; DRUG HYPERSENSITIVITY; HUMANS; LACTAMS; METHICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS; SURGICAL PROCEDURES, OPERATIVE; SURGICAL WOUND INFECTION;

EID: 2942667684     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/421095     Document Type: Review

References (90)

1. Burke JP. Infection control - a problem for patient safety. N Engl J Med 2003; 348:651-6.
2. National Nosocomial Infections Surveillance (NNIS) report, data summary from October 1986-April 1996, issued May 1996: a report from the National Nosocomial Infections Surveillance (NNIS) System. Am J Infect Control 1996; 24:380-8.
3. Auerbach AD. Prevention of surgical site infections. In: Shojania KG, Duncan BW, McDonald KM, et al., eds. Making health care safer: a critical analysis of patient safety practices. Evidence report/technology assessment no. 43. AHRQ publication no. 01-E058. Rockville, MD: Agency for Healthcare Research and Quality, 20 July 2001:221-44. Available at: http://www.ahrq.gov/clinic/ ptsafety/pdf/ptsafety.pdf. Accessed 8 December 2003.
4. Wong ES. Surgical site infection. In: Mayhall DG, ed. Hospital epidemiology and infection control. 2nd ed. Philadelphia: Lippincott, Williams & Wilkins, 1999:189-210.
5. Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20:725-30.
6. Martone WJ, Jarvis WR, Culver DH, Haley RW. Incidence and nature of endemic and epidemic nosocomial infections. In: Bennett JV, Brachman PS, eds. Hospital infections. 3rd ed. New York: Little, Brown Medical Division, 1992:577-96.
7. Hollenbeak CS, Murphy D, Dunagan WC, Fraser VJ. Nonrandom selection and the attributable cost of surgical-site infections. Infect Control Hosp Epidemiol 2002; 23:174-6.
8. Perencevich EN, Sands KE, Cosgrove SE, Guadagnoli E, Meara E, Platt R. Health and economic impact of surgical site infections diagnosed after hospital discharge. Emerg Infect Dis 2003; 9:196-203.
9. Centers for Medicare & Medicaid Services. Surgical Infection Prevention Project description. Available at: http://www.medqic.org/sip. Accessed 21 January 2004.
10. Page CP, Bohnen JM, Fletcher JR, McManus AT, Solumkin JS, Wittman DH. Antimicrobial prophylaxis for surgical wounds: guidelines for clinical care. Arch Surg 1993; 128:79-88.
11. Dellinger EP, Gross PA, Barrett TL, et al. Quality standard for antimicrobial prophylaxis in surgical procedures. Infectious Diseases Society of America. Clin Infect Dis 1994; 18:422-7.
12. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm 1999; 56:1839-88.
13. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20:250-78.
14. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 2001; 43:92-7.
15. ACOG Committee on Practice Bulletins. Antibiotic prophylaxis for gynecologic procedures. ACOG practice bulletin 23. Washington, DC: American College of Obstetricians and Gynecologists, January 2001.
16. Gilbert DN, Moellering RC, Sande MA. The Sanford guide to antimicrobial therapy. 33rd ed. Hyde Park, VT: Antimicrobial Therapy, 2003:123-4.
17. Lewis RT. Oral versus systemic antibiotic prophylaxis in elective colon surgery: a randomized study and meta-analysis send a message from the 1990s. Can J Surg 2002; 45:173-80.
18. Burke JF. The effective period of preventive antibiotic action in experimental incisions and dermal lesions. Surgery 1961; 50:161-8.
19. Polk HC Jr, Lopez-Mayor JF. Postoperative wound infection: a prospective study of determinant factors and prevention. Surgery 1969; 66:97-103.
20. Stone HH, Hooper CA, Kolb LD, Geheber CE, Dawkins EJ. Antibiotic prophylaxis in gastric, biliary and colonic surgery. Ann Surg 1976; 184:443-52.
21. Polk HC Jr, Trachtenberg L, Finn MP. Antibiotic activity in surgical incisions: the basis for prophylaxis in selected operations. JAMA 1980; 244:1353-4.
22. DiPiro JT, Vallner JJ, Bowden TA, Clark BA, Sisley JF. Intraoperative serum and tissue activity of cefazolin and cefoxitin. Arch Surg 1985; 120:829-32.
23. Classen DC, Evans RS, Pestotnik SL, Horn SD, Menlove RL, Burke JP. The timing of prophylactic administration of antibiotics and the risk of surgical-wound infection. N Engl J Med 1992; 326:281-6.
24. Fukatsu K, Saito H, Matsuda T, Ikeda S, Furukawa S, Muto T. Influences of type and duration of antimicrobial prophylaxis on an outbreak of methicillin-resistant Staphylococcus aureus and on the incidence of wound infection. Arch Surg 1997; 132:1320-5.
25. Trick WE, Scheckler WE, Tokars JL, et al. Modifiable risk factors associated with deep sternal site infection after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2000; 119:108-14.
26. Burke JP. Maximizing appropriate antibiotic prophylaxis for surgical patients: an update from LDS Hospital, Salt Lake City. Clin Infect Dis 2001; 33(Suppl 2):S78-83.
27. Meijer WS, Schmitz PI, Jeekel J. Meta-analysis of randomized, controlled clinical trials of antibiotic prophylaxis in biliary tract surgery. Br J Surg 1990; 77:283-90.
28. Kreter B, Woods M. Antibiotic prophylaxis for cardiothoracic operations: meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg 1992; 104:590-9.
29. McDonald M, Grabsch E, Marshall C, Forbes A. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg 1998; 68:388-96.
30. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000; 101:2916-21.
31. Eggimann P, Pittet D. Infection control in the ICU. Chest 2001; 120:2059-93.
32. Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003; 163:972-8.
33. Tripp DM, Brown GR. Pharmacist assessment of drug allergies. Am J Hosp Pharm 1993; 50:95-8.
34. Hung OR, Bands C, Laney G, Drover D, Stevens S, MacSween M. Drug allergies in the surgical population. Can J Anaesth 1994; 41:1149-55.
35. Pilzer JD, Burke TG, Mutnick AH. Drug allergy assessment at a university hospital and clinic. Am J Health Syst Pharm 1996; 53:2970-5.
36. Robinson JL, Hameed T, Carr S. Practical aspects of choosing an antibiotic for patients with a reported allergy to an antibiotic. Clin Infect Dis 2002; 35:26-31.
37. Anne S, Reisman RE. Risk of administering cephalosporin antibiotics to patients with history of penicillin allergy. Ann Allergy Asthma Immunol 1995; 74:167-70.
38. Solensky R. Hypersensitivity reactions to beta-lactam antibiotics. Clin Rev Allergy Immunol 2003; 24:201-20.
39. Thomas C, Stevenson M, Riley TV. Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. J Antimicrob Chemother 2003; 51:1339-50.
40. Finkelstein R, Rabino G, Mashiah T, et al. Vancomycin versus cefazolin prophylaxis for cardiac surgery in the setting of a high prevalence of methicillin-resistant staphylococcal infections. J Thorac Cardiovasc Surg 2002; 123:326-32.
41. Manian FA, Meyer PL, Setzer J, Senkel D. Surgical site infections associated with methicillin-resistant Staphylococcus aureus: do postoperative factors play a role? Clin Infect Dis 2003; 36:863-8.
42. Muto CA, Jernigan JA, Ostrowsky BE, et al. SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and Enterococcus. Infect Control Hosp Epidemiol 2003; 24:362-86.
43. Arnold MS, Dempsey JM, Fishman M, McAuley PJ, Tibert C, Vallande NC. The best hospital practices for controlling methicillin-resistant Staphylococcus aureus: on the cutting edge. Infect Control Hosp Epidemiol 2002; 23:69-76.
44. Farr BM, Jarvis WR. Would active surveillance cultures help control healthcare-related methicillin-resistant Staphylococcus aureus infections? Infect Control Hosp Epidemiol 2002; 23:65-8.
45. Jernigan JA, Pullen AL, Flowers L, Bell M, Jarvis WR. Prevalence of and risk factors for colonization with methicillin-resistant Staphylococcus aureus at the time of hospital admission. Infect Control Hosp Epidemiol 2003; 24:409-14.
46. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002; 346:1871-7.
47. Laupland KB, Conly JM. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review. Clin Infect Dis 2003; 37:933-8.
48. Suzuki Y, Kamigaki T, Fujino Y, Tominaga M, Ku Y, Kuroda Y. Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery. Br J Surg 2003; 90:1072-5.
49. Forse RA, Karam B, MacLean LD, Christou NV. Antibiotic prophylaxis for surgery in morbidly obese patients. Surgery 1989; 106:750-6.
50. Scher KS. Studies on the duration of antibiotic administration for surgical prophylaxis. Am Surg 1997; 63:59-62.
51. Ohge H, Takesue Y, Yokoyama T, et al. An additional dose of cefazolin for intraoperative prophylaxis. Surg Today 1999; 29:1233-6.
52. Zanetti G, Giardina R, Platt R. Intraoperative redosing of cefazolin and risk for surgical site infection in cardiac surgery. Emerg Infect Dis 2001; 7:828-31.
53. McEvoy GK, ed. AHFS drug information. 43rd ed. Bethesda, MD: American Society of Health-System Pharmacists, 2003.
54. Nissen D, ed. Mosby's drug consultant. 2nd ed. St. Louis: Elsevier Science, 2003.
55. Anderson PO, Knoeben JE, Troutman WG, eds. Handbook of clinical drug data. 10th ed. New York: McGraw-Hill, 2002.
56. Kurz A, Sessler DI, Lenhardt RA. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization. N Engl J Med 1996; 334:1209-15.
57. Grief R, Akca O, Horn E-P, Kurz A, Sessler DI. Supplemental perioperative oxygen to reduce the incidence of surgical wound infection. N Engl J Med 2000; 342:161-7.
58. Melling AC, Ali B, Scott EM, Leaper DJ. Effects of preoperative warming on the incidence of wound infection after clean surgery: a randomized controlled trial. Lancet 2001; 358:876-80.
59. Sessler DI, Akca O. Nonpharmacologic prevention of surgical wound infections. Clin Infect Dis 2002; 35:1397-404.
60. Pryor KO, Fahey TJ 3rd, Lien CA, Goldstein PA. Surgical site infection and the routine use of perioperative hyperoxia in a general surgical population: a randomized controlled trial. JAMA 2004; 291:79-87.
61. Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanher V, Starr A. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg 1997; 63:356-61.
62. Furnary AP, Kerr KJ, Grunkemeier GL, Starr A. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg 1999; 67:352-60.
63. Latham R, Lancaster AD, Covington JF, Pirolo JS, Thomas CS. The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients. Infect Control Hosp Epidemiol 2001; 22:607-12.
64. Hemsell DL, Johnson ER, Hemsell PG, Nobles BJ, Little BB, Heard MC. Cefazolin is inferior to cefotetan as single-dose prophylaxis for women undergoing elective total abdominal hysterectomy. Clin Infect Dis 1995; 20:677-84.
65. American College of Obstetricians and Gynecologists. ACOG practice bulletin number 47, October 2003: prophylactic antibiotics in labor and delivery. Obstet Gynecol 2003; 102:875-82.
66. Faro S, Martens MG, Hammill HA, Riddle G, Tortolero G. Antibiotic prophylaxis: is there a difference? Am J Obstet Gynecol 1990; 162:900-7.
67. Hopkins L, Smaill F. Antibiotic prophylaxis regimens and drugs for cesarean section [review]. Cochrane Database Syst Rev 2000:CD001136.
68. Cunningham FG, Leveno KJ, DePalma RT, Roark M, Rosenfeld CR. Perioperative antimicrobials for cesarean delivery: before or after cord clamping? Obstet Gynecol 1983; 62:151-4.
69. Pollard JP, Hughes SO, Scott JE, Evans MJ, Benson MK. Antibiotic prophylaxis in total hip replacement. Br Med J 1979; 1:707-9.
70. Williams DN, Gustilo RB, Beverly R, Kind AC. Bone and serum concentrations of five cephalosporin drugs: relevance to prophylaxis and treatment in orthopedic surgery. Clin Orthop 1983; 179:253-65.
71. Nelson CL, Green TG, Porter RA, Warren RD. One day versus seven days of preventive antibiotic therapy in orthopedic surgery. Clin Orthop 1983; 176:258-63.
72. Heydemann JS, Nelson CL. Short-term preventive antibiotics. Clin Orthop 1986; 205:184-7.
73. Oishi CS, Carrion WV, Hoaglund FT. Use of parenteral prophylactic antibiotics in clean orthopaedic surgery: a review of the literature. Clin Orthop 1993; 296:249-55.
74. Mauerhan DR, Nelson CL, Smith DL, et al. Prophylaxis against infection in total joint arthroplasty: one day of cefuroxime compared with three days of cefazolin. J Bone Joint Surg Am 1994; 76:39-45.
75. Magee C, Rodeheaver GT, Golden GT, Fox J, Edgerton JT, Edlich RF. Potentiation of wound infection by surgical drains. Am J Surg 1976; 131:547-9.
76. Chandratreya A, Giannikas K, Livesley P. To drain or not to drain: literature versus practice. J R Coll Surg Edinb 1998; 43:404-6.
77. Cobb JP. Why use drains? J Bone Joint Surg Br 1990; 72:993-5.
78. Adalberth G, Bystrom S, Kolstad K, Mallmin H, Milbrink J. Postoperative drainage of knee arthroplasty is not necessary: a randomized study of 90 patients. Acta Orthop Scand 1998; 69:475-8.
79. Niskanen RO, Korkala OL, Haapala J, Kuokkanen HO, Kaukonen JP, Salo SA. Drainage is of no use in primary uncomplicated cemented hip and knee arthroplasty for osteoarthritis: a prospective randomized study. J Arthroplasty 2000; 15:567-9.
80. Hadden WA, McFarlane AG. A comparative study of closed-wound suction drainage vs. no drainage in total hip arthroplasty. J Arthroplasty 1990; 5(Suppl):S21-4.
81. Ritter MA, Keating EM, Faris PM. Closed wound drainage in total hip or total knee replacement: a prospective, randomized study. J Bone Joint Surg 1994; 76:35-8.
82. Reilly TJ, Gradisar IA, Pakan W, Reilly M. The use of postoperative suction drainage in total knee arthroplasty. Clin Orthop 1986; 208:238-42.
83. Esler CN, Blakeway C, Fiddian NJ. The use of a closed-suction drain in total knee arthroplasty: a prospective randomised study. J Bone Joint Surg Br 2003; 85:215-7.
84. Beer KJ, Lombardi AV, Mallory TH, Vaughn BK. The efficacy of suction drains after routine total joint arthroplasty. J Bone Joint Surg 1991; 73:584-7.
85. Drinkwater CJ, Neil MJ. Optimal timing of wound drain removal following total joint arthroplasty. J Arthroplasty 1995; 10:185-9.
86. Willett KM, Simmons CD, Bentley G. The effect of suction drains after total hip replacement. J Bone Joint Surg 1988; 70:607-10.
87. Raves JJ, Slifkin M, Diamond DL. A bacteriologic study comparing closed suction and simple conduit drainage. Am J Surg 1984; 148:618-20.
88. Pavan MM, Malyuk DL. A cost effective approach to surgical antibiotic prophylaxis. Can J Hosp Pharm 1992; 45:151-6.
89. Brown GR, Clarke AM. Therapeutic interchange of cefazolin with metronidazole for cefoxitin. Am J Hosp Pharm 1992; 49:1946-50.
90. Nichols RL, Smith JW, Garcia RY, Waterman RS, Holmes IW. Current practices of preoperative bowel preparation among North American colorectal surgeons. Clin Infect Dis 1997; 24:609-19.